Compounds > temozolomide
Page last updated: 2024-08-16

temozolomide and u-104

temozolomide has been researched along with u-104 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audia, A; Bar, EE; Benavides, GA; Bevensee, MO; Bhat, KP; Boyd, NH; Cooper, SJ; Darley-Usmar, V; Dedhar, S; Fried, J; Gillespie, GY; Gordon, E; Griguer, C; Hackney, JR; Hjelmeland, AB; Landis, CJ; McDonald, PC; Nabors, B; Nozell, S; Scott, SE; Spina, R; Tran, AN; Walker, K; Xu, B1
Andreucci, E; Bianchini, F; Calorini, L; Carta, F; Laurenzana, A; Peppicelli, S; Ruzzolini, J; Supuran, CT1

Other Studies

2 other study(ies) available for temozolomide and u-104

ArticleYear
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.
    JCI insight, 2017, 12-21, Volume: 2, Issue:24

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Proliferation; DNA Damage; DNA, Neoplasm; Glioblastoma; Humans; Hydrogen-Ion Concentration; Mice, Nude; Neoplastic Stem Cells; Phenylurea Compounds; Sulfonamides; Temozolomide; Xenograft Model Antitumor Assays

2017
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
    Journal of enzyme inhibition and medicinal chemistry, 2019, Volume: 34, Issue:1

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Death; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; MCF-7 Cells; Molecular Structure; Phenylurea Compounds; RNA, Messenger; Structure-Activity Relationship; Sulfonamides; Temozolomide; Tumor Cells, Cultured

2019